Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UTZ BRANDS, INC. (UTZ)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Utz Brands Reports First Quarter 2026 Results and Reaffirms Full Year Guidance

Market reaction Comment Full text

BIO-TECHNE CORP (TECH)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Market reaction Comment Full text

LOEWS CORP (L)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Loblaw annonce une croissance des produits de 4,2 % et une augmentation du montant ajusté du bénéfice net dilué par action ordinaire de 10,6 % pour le premier trimestre

Market reaction Comment Full text

BIO-TECHNE CORP (TECH)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Bio-Techne Declares Dividend

Market reaction Comment Full text

APOLLO GLOBAL MANAGEMENT, INC. (APO)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Apollo Reports First Quarter 2026 Results

Market reaction Comment Full text

FRESHPET, INC. (FRPT)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Freshpet, Inc. Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

BRUKER CORP (BRKR)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Bruker Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

AmerisourceBergen (ABC)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Cencora Reports Fiscal 2026 Second Quarter Results

Market reaction Comment Full text

LOEWS CORP (L)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

Loblaw Reports First Quarter Revenue Growth of 4.2% and Adjusted Diluted Net Earnings Per Common Share Growth of 10.6%

Market reaction Comment Full text

ITT INC. (ITT)

  • Business News
  • May 06, 2026, 10:30 UTC
  • 2
  • 1 comments

ITT Reports 2026 First Quarter Earnings Per Share (EPS) of $0.89, Adjusted EPS of $1.98; Introducing Full Year Outlook Following the Closing of SPX FLOW

Market reaction Comment Full text
  • Previous
  • 473
  • 474
  • 475
  • 476
  • 477
  • Next

Search

News categories

  • Technical Exchange News(12450)
  • Event(6229)
  • SEC News(279298)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(160572)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin